A team of international scientists has recently explored the impact of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the prevalence of coronavirus disease 2019 (COVID-19) in vaccinated and unvaccinated individuals. The findings reveal that COVID-19 prevalence is significantly higher in vaccinated individuals during the omicron-dominated wave compared to that during the delta-dominated wave. However, in unvaccinated individuals, both delta and omicron variants have a similar impact on COVID-19 prevalence. The study is currently available on the Research Square* preprint server.
Study: Using Survey Data to Estimate the Impact of the Omicron Variant on Vaccine Efficacy against COVID-19 Infection. Image Credit: anushkaniroshan/Shutterstock
Background
This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources
Since its emergence in November 2021 in South Africa, the omicron variant of SARS-CoV-2 has caused a sharp rise in new infections worldwide. Because of a heavily mutated spike protein, the variant is expected to have a significantly higher ability to evade pre-existing host immunity induced by natural infection or vaccination. A sharp induction in breakthrough infections in omicron-dominated countries signifies improved immune fitness of the variant.
In 2020, researchers from the University of Maryland, USA, together with Facebook, conducted a large-scale survey (UMD Global CTIS) to prepare a database of self-reported SARS-CoV-2 infections, symptoms, testing, and COVID-19 vaccination status. Afterward, the researchers have used the survey data to assess the differences in vaccine efficacy between delta- and omicron-dominated waves. They have observed a sharp reduction in vaccine efficacy against the omicron variant.
The study
In the current study, scientists have used the UMD Global CTIS survey data to evaluate the prevalence of COVID-19 and vaccine efficacy among unvaccinated, partially vaccinated (single dose), and fully vaccinated (double dose) individuals in South Africa and other omicron-dominated countries.
The UMD Global CTIS survey collects more than 100,000 self-reported data daily worldwide. This survey uses self-reported symptoms as a proxy for active COVID-19 cases. However, a symptom-based proxy can sometimes overestimate the number of cases as similar symptoms might be shared by COVID-19 and other health conditions.
The scientists have re-analyzed the dataset using a machine-learning-based classifier to derive COVID-19 active cases to overcome this uncertainty. They have defined COVID-19 prevalence as the ratio of positive cases to the total number of responses.
COVID-19 prevalence and vaccine efficacy in South Africa
The prevalence of COVID-19 in South Africa was determined from June to December 2021. The analysis revealed that COVID-19 prevalence during the delta-dominated wave (August – September) in unvaccinated individuals is comparable to that during the omicron-dominate wave (December). In contrast, a significantly higher prevalence was observed among partially and fully vaccinated individuals during the omicron wave. Compared to partial vaccination, full vaccination provided a higher level of protection.
Regarding vaccine efficacy against infection, a clear reduction was observed during the omicron wave compared to that during the delta wave.
COVID-19 prevalence and vaccine efficacy in omicron-dominated countries
Similar to South Africa, COVID-19 prevalence and vaccine efficacy were determined for October (pre-omicron period) and December in a total of 24 omicron-dominated countries.
The analysis revealed a considerable drop in vaccine efficacy in fully vaccinated individuals during the omicron-dominated wave. However, the amplitude of reduction was smaller than that observed in South Africa. A significant negative correlation was also observed between vaccine efficacy and COVID-19 prevalence.
Study significance
The study demonstrates an increased prevalence of COVID-19 cases during the omicron-dominated wave in South Africa and other countries. The induction in prevalence is accompanied by a reduction in vaccine efficacy against SARS-CoV-2 infection. However, the study does not provide information on vaccine efficacy against severe COVID-19, hospitalization, and mortality.
This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources
Article Revisions
- May 12 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses